Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Journal of Neurology
|
June 29, 2014
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study
Aaron E Miller, Richard Macdonell, Giancarlo Comi, et al.
Epilepsy & Behavior : E&B
|
February 1, 2022
Electroclinical biomarkers of autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
Journal of Neuroimmunology
|
February 15, 2021
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis
James Broadley, Robb Wesselingh, Udaya Seneviratne, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
December 9, 2022
Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis
James Broadley, Robb Wesselingh, Paul Beech, et al.
Epilepsy & Behavior : E&B
|
May 27, 2022
Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
Neurology and Therapy
|
December 14, 2024
Long-Term Safety and Effectiveness of Dimethyl Fumarate in Patients with Multiple Sclerosis Treated in Routine Medical Practice: Final Analysis of the ESTEEM Study
Krupa Shah Pandey, Kathryn Giles, Konstantin Balashov, et al.
BMJ Neurology Open
|
July 22, 2022
Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data
Todd A Hardy, John Parratt, Heidi Beadnall, et al.
The Medical Journal of Australia
|
November 21, 2012
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series
Nigel W Crawford, Allen Cheng, Nick Andrews, et al.
BMJ Open
|
March 10, 2026
Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
Richard A A Kanaan, Richard Macdonell, Michelle Long, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine
Richard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Journal of Neurology
|
June 29, 2014
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study
Aaron E Miller, Richard Macdonell, Giancarlo Comi, et al.
Epilepsy & Behavior : E&B
|
February 1, 2022
Electroclinical biomarkers of autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
Journal of Neuroimmunology
|
February 15, 2021
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis
James Broadley, Robb Wesselingh, Udaya Seneviratne, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
December 9, 2022
Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis
James Broadley, Robb Wesselingh, Paul Beech, et al.
Epilepsy & Behavior : E&B
|
May 27, 2022
Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis
Robb Wesselingh, James Broadley, Katherine Buzzard, et al.
Neurology and Therapy
|
December 14, 2024
Long-Term Safety and Effectiveness of Dimethyl Fumarate in Patients with Multiple Sclerosis Treated in Routine Medical Practice: Final Analysis of the ESTEEM Study
Krupa Shah Pandey, Kathryn Giles, Konstantin Balashov, et al.
BMJ Neurology Open
|
July 22, 2022
Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data
Todd A Hardy, John Parratt, Heidi Beadnall, et al.
The Medical Journal of Australia
|
November 21, 2012
Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series
Nigel W Crawford, Allen Cheng, Nick Andrews, et al.
BMJ Open
|
March 10, 2026
Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
Richard A A Kanaan, Richard Macdonell, Michelle Long, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2015
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine
Richard Macdonell, Guy Nagels, David-Axel Laplaud, et al.
Page
of 6